期刊文献+

P^(16)抑制基因在腮腺多形性腺瘤预后判断中的作用 被引量:1

The roles of P^(16) gene in the development and progression of pleomorphic adenoma
下载PDF
导出
摘要 目的 探讨 P1 6 基因在腮腺多形性腺瘤发生、发展及在判断预后中的作用。方法 采用 SABC法行免疫组织化学染色 ,利用计算机图像处理系统 ,对 P1 6在腮腺多形性腺瘤中的蛋白表达进行定量检测 ,结合肿瘤细胞核形态学参数等相关数据 ,进行统计学分析处理。结果 多形性腺瘤的发生与 P1 6抑制基因密切相关 ,P1 6蛋白表达与肿瘤细胞分化程度紧密相关 ,与肿瘤生长时间呈负相关 ,P1 6蛋白的低表达、缺失可导致肿瘤的恶性发展 ,使其生物学行为恶化。结论  P1 6 抑制基因与多形性腺瘤的生物学行为关系密切 ,P1 6 蛋白可作为肿瘤分级和区别肿瘤增殖潜能的有效指标。 P1 6 蛋白缺失及低表达者应视为预后较差 。 Objective To investigate the roles of P 16 gene in the development and progression of pleomorphic adenoma.Methods Computer image analysis techniques was used to quantitate the result of immunohistochemical reaction of P 16 protein and nuclear morphologic features of neoplastic cells, the expression of P 16 gene was detected by SABC immunohistochemical staining technique.Results P 16 expression is closely related to the degree of differentiation of neoplastic cells in pleomorphic adenoma.Accumulation of p16 is negatively correlated with tumor growth time. Low expression or/and deletion of P 16 protein greatly enhance malignant progression of disease, make the biological behavior more malignant with a poor prognosis.Conclusion The biological behaviors of pleomorphic adenoma are closely correlated with P 16 expression, immunohistochemical detection of P 16 gene expression in tumor tissues may be used as a method to judge the multiplication potentiality of tumor cells. Low accumulation of P 16 protein is at high risk of developing carcinoma,closely observation should be performed in these patients after surgical treatment.
出处 《山东医药》 CAS 北大核心 2003年第26期9-11,共3页 Shandong Medical Journal
基金 山东省卫生厅青年科学研究基金资助项目 (编号 :2 0 0 1CA2 DCA4)
关键词 P16抑制基因 多形性腺瘤 免疫组织化学染色 图像分析预后 P16 gene Pleomorphic adenoma Immunohistochemistry Image analysis Prognosis
  • 相关文献

参考文献8

  • 1Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulator potentially involved in genesis of many tumor types.Science,1994,264(5157):436~440.
  • 2Serrano M,Hannon GJ,Beach D.A new regulatory motifin cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature,1993,366(6456):704~707.
  • 3Marx J.New tumor suppressor may rival P53.Science,1994,264(5157):344-345.
  • 4Walker DG,Duan W,Popovic EA,et al.Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas.Cancer Res,1995,55(1):20~23.
  • 5G.Seifert,郭传瑸.WHO涎腺肿瘤组织病理类型新分类(1991)(一)[J].现代口腔医学杂志,1993,7(4):193-196. 被引量:9
  • 6郭传.WHO涎腺肿瘤组织病理类型新分类(1991)(二)[J].现代口腔医学杂志,1994,8(1):1-6. 被引量:14
  • 7Geradts J,Kratzke RA,Niehans GA,et al.Immunohistochemical detection of CDKN2/MTS1 product P16 INK 4a in archival human solid tumors.Cancer Res,1995,55(24):6006~6011.
  • 8申洪,陆药丹.免疫组织化学染色的定量方法研究[J].生物医学工程学杂志,1993,10(4):281-284. 被引量:126

共引文献146

同被引文献15

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部